Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
17/11/2022 16:33
Nov 17 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* RIGHTS ISSUE HAS BEEN SUBSCRIBED FOR A TOTAL OF
APPROXIMATELY 77
PERCENT
* THROUGH RIGHTS ISSUE, DANCANN PHARMA RECEIVES
APPROXIMATELY DKK
22 MILLION BEFORE DEDUCTION OF ISSUE COSTS
Source text for Eikon: ID:nWkr9bGzD
Further company coverage: DANCAN.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874